Compromised Margins Following Mastectomy for Stage I-III Breast Cancer

被引：0
|
作者：
Al Mushawah, Fatema [1 ]
Aft, Rebecca L. [1 ]
Gillanders, William E. [1 ]
Eberlein, Timothy J. [1 ]
Margenthaler, Julie A. [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2011年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S162 / S162
页数：1
相关论文
共 50 条
  • [31] Integrating the symptom experience and coping in patients with stage I-III breast cancer in China: A qualitative study
    Liang, Minyu
    Xiong, Ying
    Zhu, Siying
    Wang, Yishu
    Knobf, M. Tish
    Ye, Zengjie
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2024, 73
  • [32] The prognostic implications of redox protein expression in stage I-III triple-negative breast cancer
    Lee, Soohyeon
    Kim, Da Rae
    Kim, Min Whan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] Risk factors for central nervous system (CNS) metastases in patients with stage I-III breast cancer
    Neciosup, S. P.
    Gomez, H. L.
    Cruz, W. R.
    Doimi, F. F.
    Pinto, J. A.
    Cotrina, J. M.
    Suazo, J. F.
    Carlos, V. E.
    Mauricio, L.
    Vallejos Sologuren, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] DNA ploidy as a predictive factor of tamoxifen treatment in elderly breast cancer patients stage I-III
    Pajk, B
    Cufer, T
    Zakotnik, B
    Borstnar, S
    Us-Krasovec, M
    ANNALS OF ONCOLOGY, 1998, 9 : 79 - 79
  • [35] Cytokeratin (CK)-positive bone marrow micrometastases (BMM) and survival in stage I-III breast cancer
    Braun, S
    Pantel, K
    Janni, W
    Hepp, F
    Kentenich, CRM
    Müller, P
    Gastroph, S
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S84 - S84
  • [36] The role of adjuvant chemotherapy in stage I-III male breast cancer: a SEER-based analysis
    Li, Wei-Ping
    Gao, Hong-Fei
    Ji, Fei
    Zhu, Teng
    Cheng, Min-Yi
    Yang, Mei
    Yang, Ci-Qiu
    Zhang, Liu-Lu
    Li, Jie-Qing
    Zhang, Jun-Sheng
    Wang, Kun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [37] Neoadjuvant targeted therapy in stage I-III HER2-mutant lobular breast cancer
    Kennedy, Laura C.
    Unni, Nisha
    Hanker, Ariella B.
    Arteaga, Carlos L.
    CANCER RESEARCH, 2024, 84 (07)
  • [38] Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: The AMAZONA retrospective cohort study
    Simon, Sergio Daniel
    Bines, Jose
    Werutsky, Gustavo
    Nunes, Joao Soares
    Pacheco, Fernando Chalu
    Segalla, Jose Getulio
    Gomes, Andrea J. S.
    Adam Van Eyll, Brigitte Marie H. R.
    Gimenes, Daniel Luiz
    Crocamo, Susanne
    Freitas-Junior, Ruffo
    Dal Lago, Lissandra
    Queiroz, Geraldo Silva
    de Azevedo, Sergio Jobim
    Rosa, Daniela Dornelles
    Delgado, Gilson
    Borges, Giuliano Santos
    do Nascimento, Yeni Veronica
    Zaffaroni, Facundo
    Martinez-Mesa, Jeovany
    Barrios, Carlos H. E.
    BREAST, 2019, 44 : 113 - 119
  • [39] Use of disseminated tumor cells to predict outcome in patients with stage I-III breast cancer.
    Gainer, Sarah Marie
    Krishnamurthy, Savitri
    Bhattacharyya, Anirban
    Lodhi, Ashutosh
    Hall, Carolyn S.
    Bedrosian, Isabelle
    Kuerer, Henry Mark
    Lucci, Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [40] Impact of Breast Cancer Stage on Outcomes following Mastectomy with Reconstruction
    Seth, A. K.
    Hirsch, E. M.
    Hansen, N. M.
    Fine, N. A.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S15 - S15
12345